Skip to main content
MENU
Investors Menu

Glossary of Financial Measures

Ingevity has presented certain financial measures, defined below, which have not been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and has provided a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP on the following pages. These financial measures are not meant to be considered in isolation nor as a substitute for the most directly comparable financial measure calculated in accordance with GAAP. Investors should consider the limitations associated with these non-GAAP measures, including the potential lack of comparability of these measures from one company to another.

We believe these non-GAAP financial measures provide management as well as investors, potential investors, securities analysts, and others with useful information to evaluate the performance of the business, because such measures, when viewed together with our financial results computed in accordance with GAAP, provide a more complete understanding of the factors and trends affecting our historical financial performance, liquidity measures, and projected future results.

Ingevity uses the following non-GAAP measures:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
A

  • Adjusted earnings (loss) from continuing operations

    Net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, pension and postretirement settlement and curtailment (income) charges, (gain) loss on strategic investments, debt refinancing fees, litigation verdict charges, proxy contest charges, portfolio review expenses, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.

  • Adjusted earnings (loss) from discontinued operations

    Net income (loss) plus restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, loss on CTO resales, CTO supply contract termination charges, (gain) loss on strategic investments, and the income tax expense (benefit) on those items, less the provision (benefit) from certain discrete tax items.

  • Adjusted EBITDA from continuing operations

    Net income (loss) plus interest expense, net, provision (benefit) for income taxes, depreciation, amortization, restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, litigation verdict charges, (gain) loss on strategic investments, proxy contest charges, portfolio review expenses, and pension and postretirement settlement and curtailment (income) charges, net.

  • Adjusted EBITDA from discontinued operations

    Net income (loss) plus interest expense, net, provision (benefit) for income taxes, depreciation, amortization, restructuring and other (income) charges, net, goodwill impairment charges, acquisition and other-related (income) costs, (gain) loss on strategic investments, loss on CTO resales, and CTO supply contract termination charges.

  • Adjusted EBITDA margin from continuing operations

    Adjusted EBITDA from continuing operations divided by Net sales from continued operations.

  • Adjusted EBITDA margin from discontinued operations

    Adjusted EBITDA from discontinued operations divided by Net sales from discontinued operations.

top of page
C

  • Combined Net sales

    Performance Chemicals Net sales from continuing operations plus Performance Chemicals Net sales from discontinued operations.

  • Combined Segment EBITDA

    Performance Chemicals Segment EBITDA from continuing operations plus EBITDA from discontinued operations.

  • Combined Segment EBITDA Margin

    Combined Segment EBITDA divided by Combined Net sales.

top of page
D

  • Diluted adjusted earnings (loss) from continuing operations per share

    Diluted earnings (loss) per common share plus restructuring and other (income) charges, net, per share, goodwill impairment charges per share, acquisition and other-related (income) costs per share, pension and postretirement settlement and curtailment (income) charges per share, (gain) loss on strategic investments per share, debt refinancing fees per share, litigation verdict charge per share, proxy contest charges per share, portfolio review expenses per share, and the income tax expense (benefit) per share on those items, less the provision (benefit) from certain discrete tax items per share.

  • Diluted adjusted earnings (loss) from discontinued operations per share

    Diluted earnings (loss) per common share plus restructuring and other (income) charges, net, per share, goodwill impairment charges per share, acquisition and other-related (income) costs per share, loss on CTO resales per share, CTO supply contract termination charges per share, (gain) loss on strategic investments per share, and the income tax expense (benefit) per share on those items, less the provision (benefit) from certain discrete tax items per share.

top of page
F

  • Free Cash Flow

    Sum of net cash provided by (used in) the following items: operating activities less capital expenditures.

top of page
N

  • Net Debt

    Sum of notes payable, short-term debt, current maturities of long-term debt and long-term debt including finance lease obligations less the sum of cash and cash equivalents, restricted cash associated with our new market tax credit financing arrangement, and restricted investment associated with certain finance lease obligations, excluding the allowance for credit losses on held-to-maturity debt securities held within the restricted investment.

  • Net Debt Ratio

    Net Debt divided by the last twelve months Total Adjusted EBITDA.

top of page
T

  • Total adjusted earnings (loss)

    Adjusted earnings (loss) from continuing operations and Adjusted earnings (loss) from discontinued operations.

  • Total Adjusted EBITDA

    Adjusted EBITDA from continuing operations and Adjusted EBITDA from discontinued operations.

  • Total Adjusted EBITDA margin

    Total Adjusted EBITDA divided by Total net sales.

  • Total adjusted gross margin

    Total adjusted gross profit divided by Total net sales.

  • Total adjusted gross profit

    Gross profit from continuing operations plus gross profit from discontinued operations plus depreciation and amortization.

  • Total adjusted other (income) expense, net

    Other (income) expense, net from continuing operations plus other (income) expense, net from discontinued operations less (gain) loss on strategic investments, loss on CTO resales, CTO supply contract termination charges, proxy contest charges, portfolio review expenses, depreciation and amortization.

  • Total adjusted other (income) expense, net as a percent of sales

    Total adjusted other (income) expense, net divided by Total Net sales.

  • Total adjusted SG&A

    Selling, general, and administrative costs from continuing operations plus research and technical expenses from continuing operations plus selling, general, and administrative costs from discontinued operations plus research and technical expenses from discontinued operations less depreciation and amortization.

  • Total adjusted SG&A as a percent of sales

    Total adjusted SG&A divided by Total Net sales.

  • Total diluted adjusted earnings (loss) per share

    Diluted adjusted earnings (loss) from continuing operations per share and diluted adjusted earnings (loss) from discontinued operations per share.

  • Total Net Sales

    Net sales from continuing operations and Net sales from discontinued operations.

top of page